Ergoteles’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,500
| Closed | -$21.6K | – | 566 |
|
|
2023
Q2 | $21.6K | Buy |
+2,500
| New | +$21.6K | ﹤0.01% | 985 |
|
|
2022
Q4 | – | Sell |
-1,279
| Closed | -$61K | – | 1737 |
|
|
2022
Q3 | $61K | Buy |
+1,279
| New | +$61K | ﹤0.01% | 1428 |
|
|
2022
Q2 | – | Sell |
-5,390
| Closed | -$436K | – | 1880 |
|
|
2022
Q1 | $436K | Buy |
5,390
+3,503
| +186% | +$283K | 0.02% | 711 |
|
|
2021
Q4 | $382K | Sell |
1,887
-3,500
| -65% | -$709K | 0.01% | 753 |
|
|
2021
Q3 | $1.45M | Sell |
5,387
-1,122
| -17% | -$302K | 0.05% | 309 |
|
|
2021
Q2 | $1.68M | Buy |
6,509
+4,669
| +254% | +$1.2M | 0.04% | 395 |
|
|
2021
Q1 | $552K | Sell |
1,840
-5,333
| -74% | -$1.6M | 0.02% | 470 |
|
|
2020
Q4 | $1.83M | Buy |
+7,173
| New | +$1.83M | 0.06% | 260 |
|